Anpac Bio Correlations
| ANPCDelisted Stock | USD 4.37 0.20 4.38% |
The current 90-days correlation between Anpac Bio Medical and Anebulo Pharmaceuticals is 0.04 (i.e., Significant diversification). The correlation of Anpac Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Anpac Bio Correlation With Market
Good diversification
The correlation between Anpac Bio Medical and DJI is -0.16 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Anpac Bio Medical and DJI in the same portfolio, assuming nothing else is changed.
Anpac |
Moving together with Anpac Stock
| 0.72 | NVO | Novo Nordisk AS | PairCorr |
| 0.7 | NONOF | Novo Nordisk AS | PairCorr |
| 0.65 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.63 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Anpac Stock
| 0.83 | MET | MetLife | PairCorr |
| 0.77 | JXN-PA | Jackson Financial | PairCorr |
| 0.73 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.72 | NVDA | NVIDIA | PairCorr |
| 0.72 | META | Meta Platforms Aggressive Push | PairCorr |
| 0.68 | AAPL | Apple Inc Aggressive Push | PairCorr |
| 0.58 | BMYMP | Bristol Myers Squibb | PairCorr |
| 0.46 | GOOG | Alphabet Class C Aggressive Push | PairCorr |
| 0.43 | AMZN | Amazon Inc Aggressive Push | PairCorr |
| 0.79 | HD | Home Depot | PairCorr |
| 0.77 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.69 | HPQ | HP Inc | PairCorr |
| 0.67 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.65 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.63 | XOM | Exxon Mobil Corp Sell-off Trend | PairCorr |
| 0.59 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.57 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.57 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.57 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.53 | DIS | Walt Disney Aggressive Push | PairCorr |
| 0.5 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Anpac Stock performing well and Anpac Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Anpac Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ANEB | 4.86 | (0.19) | 0.00 | (0.01) | 0.00 | 8.61 | 76.00 | |||
| AVTE | 2.44 | 0.45 | 0.18 | 0.60 | 2.04 | 5.58 | 19.11 | |||
| ACRV | 2.87 | (0.45) | 0.00 | (0.13) | 0.00 | 7.66 | 22.84 | |||
| OPT | 3.21 | 0.26 | 0.07 | 0.32 | 3.83 | 9.15 | 24.20 | |||
| ANTX | 2.25 | 0.55 | 0.19 | 0.70 | 1.69 | 6.00 | 28.03 | |||
| LUMO | 2.29 | 0.22 | 0.00 | (0.21) | 2.91 | 5.95 | 16.25 | |||
| MRKR | 5.40 | (0.10) | 0.02 | 0.09 | 6.03 | 9.72 | 37.38 | |||
| XCUR | 13.03 | 5.06 | 0.72 | 1.40 | 6.09 | 47.72 | 95.22 | |||
| PTIX | 6.55 | 0.55 | 0.03 | (0.26) | 7.66 | 18.33 | 47.50 | |||
| PMVP | 1.56 | (0.03) | (0.03) | 0.08 | 1.99 | 3.75 | 13.98 |
View Anpac Bio Related Equities
| Risk & Return | Correlation |
Anpac Bio Corporate Management
| Sunil Pandit | US Officer | Profile | |
| Xiaoyu Li | CFO Director | Profile | |
| Weidong Dai | China Pres | Profile | |
| Haohan Xu | CoCEO CoChairperson | Profile | |
| He Yu | CoFounder Officer | Profile | |
| Chris Yu | CoCEO CoFounder | Profile |
Still Interested in Anpac Bio Medical?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.